These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2524143)

  • 1. [The immune status of patients with foot mycosis and eczema].
    Iutskovskiĭ AD
    Vestn Dermatol Venerol; 1989; (1):52-7. PubMed ID: 2524143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Modification of the Rebuck test and its use in the differentiated evaluation of the activity of the phagocytic reactions in patients with mycoses of the feet and eczema].
    Iutskovskiĭ AD; Lavrik AG
    Lab Delo; 1988; (10):27-9. PubMed ID: 2462081
    [No Abstract]   [Full Text] [Related]  

  • 3. [Specific and nonspecific reactivity in foot mycoses in combination with pyoderma, eczema and psoriasis].
    Zakharova TI; Piatikop AI; Ostrovskiĭ VN
    Vestn Dermatol Venerol; 1975 Apr; (4):76-9. PubMed ID: 1154896
    [No Abstract]   [Full Text] [Related]  

  • 4. PHA skin test-correlation with migration inhibition but not with peripheral blood lymphocytes (PBL) subpopulations. With 1 figure.
    Szczylik C; Wiktor-Jedrzejczak W
    Allerg Immunol (Leipz); 1981; 27(3):162-7. PubMed ID: 6214937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Circulating immune complexes in mycoses and eczema of the skin of the feet].
    Iutskovskiĭ AD; Leshchenko GM; Fedotov VP
    Vestn Dermatol Venerol; 1988; (1):22-6. PubMed ID: 3364015
    [No Abstract]   [Full Text] [Related]  

  • 6. [The functional characteristics of the interaction of lymphokine-producing lymphocytes with granulocytes of the peripheral blood and skin in dermatosis patients].
    Kozin VM; Adamenko GP; Bogdanovich LI; Iakirevich EV
    Vestn Dermatol Venerol; 1990; (3):29-32. PubMed ID: 2195796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Deficiency of immunological systems as a cause of dermatophytic onychomycosis (author's transl)].
    Lestschenko WM; Fedotow WP
    Mykosen; 1982 May; 25(5):237-47. PubMed ID: 6212761
    [No Abstract]   [Full Text] [Related]  

  • 8. Spontaneous release of leukocyte migration inhibition factor (LMIF) by lymphocytes in chronic lymphatic leukemia patients.
    Crivii SM; Crişan M; Crişan M
    Arch Geschwulstforsch; 1984; 54(1):85-9. PubMed ID: 6367694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological monitoring in lung cancer: use of the leukocyte migration inhibition assay.
    Abai AM; Fekete B
    Haematologia (Budap); 1982; 15(1):111-25. PubMed ID: 6749608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The function of neutrophils in dermatoses].
    Iutskovskiĭ AD; Logunov VP; Tishkin VS
    Lab Delo; 1991; (8):54-7. PubMed ID: 1724511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Differential clinico-laboratory parallels in mycoses and eczema of the feet].
    Iutskovskiĭ AD; Fedotov VP; Leshchenko GM
    Vestn Dermatol Venerol; 1987; (10):11-6. PubMed ID: 3424964
    [No Abstract]   [Full Text] [Related]  

  • 12. Response of bacterial antigen in palmoplantar pustulosis.
    Ishibashi A; Tsuru S; Zinnaka Y; Fujita K
    J Clin Lab Immunol; 1986 Oct; 21(2):93-6. PubMed ID: 3820277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value for survival of lymphocytes and polymorphonuclear leukocytes in patients with sepsis.
    McCredie JA; Austin TW; Holliday RL; Sibbald WJ
    Can J Surg; 1979 Sep; 22(5):447-51. PubMed ID: 315258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Quantitative and qualitative changes in sensitized peripheral blood lymphocytes in mycoses of the feet].
    Fedotov VP; Konshina RP
    Vestn Dermatol Venerol; 1976 Feb; (2):32-5. PubMed ID: 1084648
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunopathology in foot and hand mycoses and their combined therapy using dekaris].
    Ruslanov DV
    Vestn Dermatol Venerol; 1982 Oct; (10):20-4. PubMed ID: 6983791
    [No Abstract]   [Full Text] [Related]  

  • 16. [Dynamics of the immune status of patients with mycosis of the feet and concomitant eczema during T-activin therapy].
    Iutskovskiĭ AD; Fedotov VP; Leshchenko GM
    Vestn Dermatol Venerol; 1986; (7):17-21. PubMed ID: 3765804
    [No Abstract]   [Full Text] [Related]  

  • 17. Cell-mediated immunity in herpetic keratitis measured by leukocyte migration inhibition.
    Polack FM; Habash N; Zam ZS; Burdette MG
    Ann Ophthalmol; 1982 Sep; 14(9):825-7. PubMed ID: 6295252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The glycolytic status of peripheral blood phagocytes and its therapeutic correction in patients with foot mycoses].
    Leshchenko VM; Svirid SG
    Vestn Dermatol Venerol; 1989; (7):8-10. PubMed ID: 2816024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of fungal foot infections in patients with diabetes mellitus type 1 - underestimation of moccasin-type tinea.
    Mayser P; Hensel J; Thoma W; Podobinska M; Geiger M; Ulbricht H; Haak T
    Exp Clin Endocrinol Diabetes; 2004 May; 112(5):264-8. PubMed ID: 15146373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leucocyte migration inhibition test results during desensitization treatment of children with atopic asthma.
    Sychłowy A
    Pharmatherapeutica; 1980; 2(6):397-400. PubMed ID: 7001494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.